Home/Filings/4/0001209191-21-009033
4//SEC Filing

Parini Michael 4

Accession 0001209191-21-009033

CIK 0000875320other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 7:44 PM ET

Size

8.5 KB

Accession

0001209191-21-009033

Insider Transaction Report

Form 4
Period: 2021-02-05
Transactions
  • Sale

    Common Stock

    2021-02-05$215.00/sh1,930$414,95057,227 total
  • Exercise/Conversion

    Common Stock

    2021-02-05$86.52/sh+1,930$166,98459,157 total
  • Exercise/Conversion

    Common Stock

    2021-02-051,9300 total
    Exercise: $86.52Exp: 2027-02-02Common Stock (1,930 underlying)
Footnotes (2)
  • [F1]Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
  • [F2]Fully vested.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001661567

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:44 PM ET
Size
8.5 KB